1188 related articles for article (PubMed ID: 24831787)
21. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.
Howes AL; Richardson RD; Finlay D; Vuori K
PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711
[TBL] [Abstract][Full Text] [Related]
22. Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture.
Ryan SL; Baird AM; Vaz G; Urquhart AJ; Senge M; Richard DJ; O'Byrne KJ; Davies AM
Assay Drug Dev Technol; 2016; 14(1):19-28. PubMed ID: 26866750
[TBL] [Abstract][Full Text] [Related]
23. Surface Acoustic Waves (SAW)-Based Biosensing for Quantification of Cell Growth in 2D and 3D Cultures.
Wang T; Green R; Nair RR; Howell M; Mohapatra S; Guldiken R; Mohapatra SS
Sensors (Basel); 2015 Dec; 15(12):32045-55. PubMed ID: 26703604
[TBL] [Abstract][Full Text] [Related]
24. A novel three-dimensional cell culture method enhances antiviral drug screening in primary human cells.
Koban R; Neumann M; Daugs A; Bloch O; Nitsche A; Langhammer S; Ellerbrok H
Antiviral Res; 2018 Feb; 150():20-29. PubMed ID: 29224735
[TBL] [Abstract][Full Text] [Related]
25. New Frontiers in Three-Dimensional Culture Platforms to Improve Diabetes Research.
Mohandas S; Gayatri V; Kumaran K; Gopinath V; Paulmurugan R; Ramkumar KM
Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986591
[TBL] [Abstract][Full Text] [Related]
26. A novel tissue-engineered 3D tumor model for anti-cancer drug discovery.
Li W; Hu X; Yang S; Wang S; Zhang C; Wang H; Cheng YY; Wang Y; Liu T; Song K
Biofabrication; 2018 Oct; 11(1):015004. PubMed ID: 30229749
[TBL] [Abstract][Full Text] [Related]
27. Implementation and Use of State-of-the-Art, Cell-Based In Vitro Assays.
Langer G
Handb Exp Pharmacol; 2016; 232():171-90. PubMed ID: 26424721
[TBL] [Abstract][Full Text] [Related]
28. The Volume of Three-Dimensional Cultures of Cancer Cells InVitro Influences Transcriptional Profile Differences and Similarities with Monolayer Cultures and Xenografted Tumors.
Boghaert ER; Lu X; Hessler PE; McGonigal TP; Oleksijew A; Mitten MJ; Foster-Duke K; Hickson JA; Santo VE; Brito C; Uziel T; Vaidya KS
Neoplasia; 2017 Sep; 19(9):695-706. PubMed ID: 28787674
[TBL] [Abstract][Full Text] [Related]
29. The application of 3D cell models to support drug safety assessment: opportunities & challenges.
Roth A; Singer T
Adv Drug Deliv Rev; 2014 Apr; 69-70():179-89. PubMed ID: 24378580
[TBL] [Abstract][Full Text] [Related]
30. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization.
Eglen RM; Reisine T
SLAS Technol; 2019 Feb; 24(1):3-17. PubMed ID: 30286296
[TBL] [Abstract][Full Text] [Related]
31. Implications of adipose-derived stromal cells in a 3D culture system for osteogenic differentiation: an in vitro and in vivo investigation.
Shen FH; Werner BC; Liang H; Shang H; Yang N; Li X; Shimer AL; Balian G; Katz AJ
Spine J; 2013 Jan; 13(1):32-43. PubMed ID: 23384881
[TBL] [Abstract][Full Text] [Related]
32. AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies.
Godugu C; Patel AR; Desai U; Andey T; Sams A; Singh M
PLoS One; 2013; 8(1):e53708. PubMed ID: 23349734
[TBL] [Abstract][Full Text] [Related]
33. Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines.
Muguruma M; Teraoka S; Miyahara K; Ueda A; Asaoka M; Okazaki M; Kawate T; Kuroda M; Miyagi Y; Ishikawa T
Biochem Biophys Res Commun; 2020 Dec; 533(3):268-274. PubMed ID: 32958246
[TBL] [Abstract][Full Text] [Related]
34. Quantitative Proteomic Analysis of 2D and 3D Cultured Colorectal Cancer Cells: Profiling of Tankyrase Inhibitor XAV939-Induced Proteome.
Kim YE; Jeon HJ; Kim D; Lee SY; Kim KY; Hong J; Maeng PJ; Kim KR; Kang D
Sci Rep; 2018 Sep; 8(1):13255. PubMed ID: 30185973
[TBL] [Abstract][Full Text] [Related]
35. A simple, reliable method for high-throughput screening for diabetes drugs using 3D β-cell spheroids.
Amin J; Ramachandran K; Williams SJ; Lee A; Novikova L; Stehno-Bittel L
J Pharmacol Toxicol Methods; 2016; 82():83-89. PubMed ID: 27554916
[TBL] [Abstract][Full Text] [Related]
36. Generation and analysis of 3D cell culture models for drug discovery.
Belfiore L; Aghaei B; Law AMK; Dobrowolski JC; Raftery LJ; Tjandra AD; Yee C; Piloni A; Volkerling A; Ferris CJ; Engel M
Eur J Pharm Sci; 2021 Aug; 163():105876. PubMed ID: 33989755
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 2D and 3D cell culture models for cell growth, gene expression and drug resistance.
Fontoura JC; Viezzer C; Dos Santos FG; Ligabue RA; Weinlich R; Puga RD; Antonow D; Severino P; Bonorino C
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110264. PubMed ID: 31761183
[TBL] [Abstract][Full Text] [Related]
38. Real-time monitoring of 3D cell culture using a 3D capacitance biosensor.
Lee SM; Han N; Lee R; Choi IH; Park YB; Shin JS; Yoo KH
Biosens Bioelectron; 2016 Mar; 77():56-61. PubMed ID: 26386332
[TBL] [Abstract][Full Text] [Related]
39. Three-dimensional cell culture: the missing link in drug discovery.
Breslin S; O'Driscoll L
Drug Discov Today; 2013 Mar; 18(5-6):240-9. PubMed ID: 23073387
[TBL] [Abstract][Full Text] [Related]
40. Three-dimensional cell culture models for anticancer drug screening: Worth the effort?
Verjans ET; Doijen J; Luyten W; Landuyt B; Schoofs L
J Cell Physiol; 2018 Apr; 233(4):2993-3003. PubMed ID: 28618001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
